Ipratropium Bromide Solution
Product Images NDC 0487-9801

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 0487-9801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nephron Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

97e130d5-figure-01 (97e130d5 Figure 01)

97e130d5-figure-01 (97e130d5 Figure 01)
The text appears to be a chemical formula and some related information about a compound called "pratropium bromide" with the molecular formula C..H,,BINO,-H,0 and having a monohydrate molecular weight of 430.4. It is commonly used to treat lung conditions such as chronic obstructive pulmonary disease (COPD) and asthma.*
FDA Label Image

97e130d5-figure-02 (97e130d5 Figure 02)

FDA Label Image

97e130d5-figure-03 (97e130d5 Figure 03)

FDA Label Image

97e130d5-figure-04 (97e130d5 Figure 04)

FDA Label Image

97e130d5-figure-05 (97e130d5 Figure 05)

97e130d5-figure-05 (97e130d5 Figure 05)
This is a medication called Ipratropium Bromide Inhalation Solution with a concentration of 0.02% in a 0.5mg/2.5mL solution for oral inhalation only. It is contained in a low-density polyethylene vial which is preservative-free, isotonic, sterile, and contains sodium chloride adjusted to pH 3.4 (3 to 4) with hydrochloric acid. It is intended for use as directed by the accompanying prescribing information and should be stored between 15° and 30°C (59° and 86°F), away from light, and unused vials should be stored in the foil pouch. The medication is manufactured by Nephron Pharmaceuticals Corporation based in West Columbia, SC 29172, and customer service can be reached by calling 1-800-443.4313.*
FDA Label Image

97e130d5-figure-06 (97e130d5 Figure 06)

97e130d5-figure-06 (97e130d5 Figure 06)
This is a label for a medication with the National Drug Code (NDC) of 0487-9801-25. It comes in a vial with a volume of 2.5 milliliters and a strength of 0.5 milligrams. It is for oral inhalation only and is not intended for injection. The label warns that it is only for adult use and should be used with caution for those with hypertension. It is available in a package of 25 sterile unit-dose vials and requires a prescription.*
FDA Label Image

97e130d5-figure-07 (97e130d5 Figure 07)

97e130d5-figure-07 (97e130d5 Figure 07)
This appears to be a medication called Tropium Bromide, which comes in a 2.5mL sterile unit-dose vial. It is not intended for injection and is meant for topical use only. The text includes prescription information and batch numbers.*
FDA Label Image

97e130d5-figure-08 (97e130d5 Figure 08)

97e130d5-figure-08 (97e130d5 Figure 08)
Ipratropium Bromide Inhalation Solution is a prescription medicine that contains 0.02% Ipratropium Bromide. This is used for inhalation by patients only, and not for any other kind of injection. It is available in 05mg/25mvial, and it should not be used for any other purpose than the one mentioned in the prescription. The NOC number for this product is 0487080160.*
FDA Label Image

97e130d5-figure-09 (97e130d5 Figure 09)

97e130d5-figure-09 (97e130d5 Figure 09)
This is a medication with the NDC code 0487-9801-01 used for oral inhalation containing Ipratropium Bromide, 0.5mg in 2.5mL saline solution. The medication is not intended for injection and is usually dosed with a prescription. The medication is stored at a temperature between 15°C and 30°C. The medication is manufactured by Nephron Pharmaceuticals Corporation and is available in a unit-dose vial.*
FDA Label Image

97e130d5-figure-10 (97e130d5 Figure 10)

FDA Label Image

97e130d5-figure-11 (97e130d5 Figure 11)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.